Versant Venture Capital VI, L.P. 13D/13G Filings for PANDION THERAPEUTICS INC (PAND)

Versant Venture Capital VI, L.P. 13D and 13G filings for PANDION THERAPEUTICS INC:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2020-07-31
4:26 pm
Purchase
2020-07-2113GPANDION THERAPEUTICS INC
PAND
Versant Venture Capital VI, L.P.3,176,507
11.100%
3,176,507increase
(New Position)
Filing